Clinical Trials

Aseptika is developing a home-based rapid and quantitative biomarker test for a common bacterial lung infection and 3rd generation devices for use with long-term lung disease sufferers. Clinical trials will be undertaken with NHS partners to validate their clinical effectiveness.

Sign up to our Newsletter